Bioventus (BVS) Stock Statistics & Valuation Metrics

Bioventus has a market cap or net worth of $601.08M. The enterprise value is $831.80M.

Bioventus has 66,892,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioventus’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -1.96%.

The current PE Ratio of Bioventus is ―. Bioventus’s PEG ratio is ―.

In the last 12 months, Bioventus had revenue of 573.28M and earned -33.54M in profits. Earnings per share was -0.75.

In the last 12 months, operating cash flow was 36.24M and capital expenditures -2.15M, giving a free cash flow of 34.10M billion.

Bioventus pays an annual dividend of ―, resulting in a dividend yield of ―

Bioventus upcoming earnings date is Nov 11, 2025, After Close (Confirmed).

Bioventus as a current ratio of 1.31, with Debt / Equity ratio of 26.89%

In the past 12 months, Bioventus has paid -5.29M in taxes.

Bioventus EV to EBITDA ratio is -19.78, with an EV/FCF ratio of 25.94.

Bioventus has $32.91M in cash and marketable securities with $341.24M in debt, giving a net cash position of $308.33M billion.

Gross margin is 67.60%, with operating margin of -2.09%, and net profit margin of -5.85%.

The average price target for Bioventus is $13.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy